Studies on trypsin-specific compounds are useful for the design of clinically useful compounds, since a variety of physiologically important enzymes (e.g., enzymes of the blood-clotting cascade, kallikrein and urokinase) have trypsin-like specificity. Several benzamidine and phenylguanidine derivatives have been reported to be potent inhibitors of trypsin-like enzymes.
gen atom of the Schiff base forms a hydrogen bond with Ser195. This result suggests new avenues for the design of even more potent inhibitors based on combining a metal chelate motif with a cationic S1 recognition element. For example, guanidine-containing Schiff base metal chelates may show higher affinity for trypsin than amidine-containing chelates, because the distance between the positive charge of the guanidinium group and the metal ion is approximately 1.3 Å longer than that of the amidine-containing Schiff base metal chelate. In the meta-substituted guanidine-based inhibitors therefore, the increased chain length of the inhibitor may allow tighter coordination between the metal ion and the imidazole nitrogen of His57 of trypsin than amidine-based inhibitors. Furthermore, the guanidinium group has three nitrogen atoms, which may form hydrogen bonds with S1 site residues of trypsin or solvent molecule, and then the interaction between the inhibitor and active site residue of trypsin is expected to be stronger than that of the amidine-based inhibitor. To confirm the above assumption, guanidine-containing Schiff base copper(II) and iron(III) chelates were synthesized. In addition, amidine-and guanidine-containing Schiff base zinc(II) chelates were synthesized, since zinc(II) ion is known to be one of the important elements found in metalloproteins or metalloenzymes.
This paper deals with both the syntheses of Schiff base metal chelates and the study their inhibitory activity against bovine b-trypsin with the final goal of discovering clinically useful chelate compounds.
Results and Discussion
Syntheses and Characterization 3-Formyl-4-hydroxyphenylguanidine hydrochloride (6) , a key compound in this study, was prepared from 2-hydroxy-5-nitrobenzaldehyde (1) as shown in Chart 1. The formyl group in compound 1 was protected with ethylene glycol in the presence of p-toluenesulfonic acid in benzene to give rise to the acetal (2). Amine compound 3 was obtained by catalytic hydrogenation of 2 in dioxane-EtOH. Compound 3 was reacted with the amidination reagent 1-[N,NЈ-bis(Z)amidino]pyrazole, which was prepared according to the reported procedure 26, 27) in THF to give 4. Deprotection of the bis(Z) compound 4 was carried out by catalytic hydrogenation over 10% Pd-C in EtOH-Et 2 O to give 5, and then treated with 2 M HCl to give 6. Since compound 6 undergoes rapid decomposition when converted to the free base, the compound must be kept acidic during purification and storage. The structure of 6 was assigned on the basis of IR and NMR spectra and elemental analysis. The IR spectrum of 6 is shown by broad strong bands in the region of 3150-3400 cm Ϫ1 due to typical amine absorptions (NH stretching) and the strong band at 1657 cm Ϫ1 is assigned to CϭN streching. 28) The physical and spectral data of compounds 2-6 are listed in Table 1 .
Syntheses of the guanidine-containing Schiff base copper(II) (7a-i) and zinc(II) chelates (8a-i) were achieved by mixing equimolar amounts of 6, L-amino acids, and copper(II) or zinc(II) acetate, respectively. The corresponding iron(III) chelates (9a-i) were obtained by adding iron(II) acetate to a solution of a stoichiometric amount of 6 and L-amino acids. The amidine-containing Schiff base zinc(II) chelates (10a-i) were prepared from 3-formyl-4-hydroxybenzamidine hydrochloride, 23) L-amino acids, and zinc(II) acetate.
Structural formulae of the metal chelates (7-10) are shown in Fig. 1 , and the physical and spectral data are summarized in Table 2 . The structure of copper(II) and iron(III) chelates (7, 9) is readily assigned on the basis of their elemental analysis and spectral properties. In our previous studies of amidine-containing copper(II) (11) and iron(III) chelates (12) , 23, 24) formation of the Schiff base metal chelate was ascertained by the appearance of a marked absorption at 360-380 nm for copper(II) chelates and at 430-475 nm for iron(III) chelates, which can be attributed to a p®p* transition originating mainly from the azomethine chromophore. The absorption spectra of 7 and 9 are consistent with those of 11 and 12, respectively. In the IR spectra, the copper(II) and iron(III) chelates (7b, 9b) showed characteristic bands at 3100-3450 cm
Ϫ1
, ca. 1670 cm Ϫ1 , ca. 1640 cm
, ca. 1620 cm
, and ca. 1300 cm
. The broad band in the region of 3100-3450 cm Ϫ1 is due to n(H 2 O) and n(NH). The band at ca. 1670 cm Ϫ1 is assigned to be n(CϭN) of the guanidinium group. The bands at ca. 1640 cm Ϫ1 and ca. 1620 cm Ϫ1 are assigned to n(CϭN) and n(COO Ϫ ), respectively, indicating coordination through imine nitrogen and carboxyl oxygen to the metal ion. 29, 30) The phenolic C-O vibration band in chelates appeared at ca. 1300 cm
. This is evidence of the bonding of the metal ion with phenolic oxygen, since the phenolic n(C-O) in the free Schiff base is usually found near 1280 cm
. 31) In addition, elemental analysis of chelates indicated the ratio of metal to Schiff base ligand is 1 : 1 for copper(II) chelate and 1 : 2 for iron(III) chelate. From these observations, the coordination of copper(II) chelates was revealed to be a square planar geometry, and copper(II) ion coordinates to carboxyl oxygen, imine nitrogen, phenolic oxygen of Schiff base ligand, and a Formula H 2 O molecule as shown in Fig. 1 . 23, 32, 33) On the other hand, the CϭN stretching band of the iron(III) chelate (9b) is shifted to a higher-frequency region (1629 cm
) of 7b, and the n(COO Ϫ ) band of 9b is broadened by overlapping with n(CϭN) stretching. This is typical behavior of the bis(salicylideneamino acidato)iron(III) chelates. 24, 30) Thus the iron(III) ion was concluded to have octahedral coordination geometry with two Schiff base ligands, as shown in Fig. 1 . 24, 30, 34, 35) Schiff base zinc(II) chelates derived from salicylaldehyde and amino acid are considered to have a four-coordination structure on the basis of their spectral properties, though Xray diffraction data have not been available. The IR and absorption spectra of zinc(II) chelates (8b, 10b) were very similar to those of [(salicylideneamino acidato)(H 2 O)]zinc(II) chelates. [36] [37] [38] Furthermore, elemental analysis of 8b and 10b indicated the ratio of metal to Schiff base ligand is 1 : 1. These results indicate that zinc(II) ion is tetrahedrally coordinated by a Schiff base ligand and a H 2 O molecule.
Inhibition Constant (K i ) of Chelates against Bovine b b-
Trypsin The inhibitory activity of the chelates (7-10) against bovine b-trypsin was determined according to the reported procedure, 23, 24) and the K i values are listed in Table 3 . The K i values (ca. 10 Ϫ5 M) of the guanidine-containing Schiff base copper(II) (7a-i) and zinc(II) chelates (8a-i) indicate strong inhibition. On the other hand, remarkable inhibitory activity was not observed for iron(III) chelates except for 9a and 9b.
From the result of crystal structures of the amidine-based Schiff base inhibitor-trypsin complexes, 25) we anticipated that the increase in chain length between the guanidinium nitrogens, which form an ion pair with carboxyl oxygens of Asp189 in trypsin, and metal ion in the inhibitors must result in tighter interaction with the catalytic site and S1 site of trypsin. Especially, the bond distance of metal-His57 must be shorter than that of the amidine-based inhibitor, that is, the inhibitory activity of guanidine-based inhibitors must be higher than corresponding amidine-based inhibitors. Unexpectedly, the inhibition against bovine b-trypsin of guanidine-containing copper(II) (7a-i) and zinc(II) (8a-i) chelates was less than that of the corresponding amidinecontaining copper(II) (11a-h) and zinc(II) chelates (10a-i). This result suggests that the conformation of the active site of trypsin is a better fit for the amidine-based inhibitor than the guanidine-based inhibitor. Previous X-ray crystallographic studies indicated that the cationic guanidinium group formed salt bridge interactions with the carboxylate group of Asp189 in trypsin. 17, 18) Thus a difference in the pK a value between the amidinium group and guanidinium group is the most important reason why the inhibitory activity does not increase with guanidine-based inhibitors. The reported pK a values for p-hydroxyphenylguanidinium ion and p-hydroxybenzamidinium ion are 9.05 and 12.69, respectively. 39, 40) In the iron(III) chelates, the K i values of 9a and 9b derived from Gly or Ala were comparable to those of the copper(II) and zinc(II) chelates, although the inhibitory activity of 9c-i was very weak. At a higher concentration of 9c-i, competitive inhibition with K i values of ca. 10 Ϫ3 M, which is comparable to that for the binding of an aromatic compound to trypsin, was found. 41) In the model fitting of trypsin with 9b, it was simulated that one of the Schiff base ligands would orient closely to the catalytic triad (His57, Asp102, Ser195) in such a manner that the guanidinium nitrogens of 9b form an ion pair with carboxyl oxygens of Asp189. Probably, octahedrally coordinated iron(III) chelates derived from amino acids (which have bulky side chains on the a-carbon) such as Val, Leu, Ile, and Phe could not be included in the active site of trypsin due to unfavorable interactions with the active site residues. This is supported by the results of crystal structures of bis(m-amidinosalicylidene-L-alaninato)iron(III) (12b) and bis(p-amidinosalicylidene-L-alaninato)iron(III) (13b) bound to bovine trypsin. 25) The refined structure of the trypsin-12b complex showed that inhibitor 12b did not bind to the trypsin, whereas inhibitor 13b was bound. In the case of the trypsin-12b complex, the iron(III) ion was replaced by magnesium ion which was present in the mother liquor, and one of the Schiff base ligands was replaced by solvent molecules to avoid unfavorable interactions with the active site residues.
The K i values of guanidine-or amidine-containing Schiff base zinc(II) chelates (8a-i, 10a-i) were somewhat larger than those of the corresponding copper(II) chelates (7a-i) and (11a-i), 23) respectively (Table 3 ). This observation implies that the coordination geometry of copper(II) ion is a better fit for the active site of trypsin than that of zinc(II) ion.
Further details of structural requirements for trypsin-inhibitor complex using the X-ray diffraction method will be described in a future paper.
In this study, the design of guanidine-based inhibitors with higher inhibitory activity than amidine-based inhibitors against bovine b-trypsin was not successful, although this approach will hopefully lead to the final goal of discovering clinically useful chelate compounds that inhibit trypsin-like enzymes.
Experimental
Materials 2-Hydroxy-5-nitrobenzaldehyde and iron(II) acetate were purchased from Aldrich Chemical Co., Ltd. Bovine b-trypsin (EC 3.4.21.4) was purchased from Worthington Biochemical Corp. (twice crystallized).
Instruments Melting points were measured on a Yanagimoto micro melting point apparatus.
1 H-NMR spectra were recorded on a JNM-FX-400 spectrometer (JEOL). IR and absorption spectra were recorded on a FT/IR VALOR-III spectrometer (JASCO) and a U-2000 spectrophotometer (Hitachi), respectively.
Synthesis of 2-(1,4-Dioxa-5-cyclopentyl)-4-nitrophenol (2)
A solution of 2-hydroxy-5-nitrobenzaldehyde (1) (8.3 g, 49.7 mmol), ethylene glycol (15.5 g, 250 mmol), and p-toluenesulfonic acid (0.2 g, 1.1 mmol) in benzene (400 ml) was refluxed for 4 h using the distilling receiver for water. The solution was transferred to a separatory funnel and the benzene layer was separated, washed with water and saturated NaCl solution, dried over anhydrous Na 2 SO 4 , and evaporated to dryness in vacuo. The residue was purified by recrystallization from benzene to give 2 (7.8 g, yield 74%) as a colorless crystalline powder. Physical properties and spectral data are given in Table 1 .
4-Amino-2-(1,4-dioxa-5-cyclopentyl)phenol (3) Palladium-activated carbon (Pd 10%) (200 mg) was added to a solution of 2 (2.1 g, 9.9 mmol) in dioxane-EtOH (5 : 1) (300 ml), and the mixture was vigorously stirred for 1 h under an atmosphere of hydrogen at room temperature. The catalyst was filtered off, and the filtrate was evaporated to dryness in vacuo. The residue was purified by recrystallization from EtOH-hexane to give 3 (1.6 g, yield 89%) as pale brown needles. Physical properties and spectral data are given in Table 1 .
4-[N,N؆-Bis(benzyloxycarbonyl)guanidino]-2-(1,4-dioxa-5-cyclopentyl)phenol (4)
A solution of 3 (0.9 g, 5.0 mmol) and 1-[N,NЈ-bis(Z)amidino]pyrazole (1.7 g, 5.0 mmol) in anhydrous THF (1.0 ml) was stirred for 1 h at room temperature. The reaction mixture was concentrated in vacuo. The residue was purified by silica gel column chromatography. The eluate [benzene-ethyl acetate (6 : 1)] was evaporated to dryness in vacuo and the solid residue was recrystallized from benzene-hexane to give 4 (2.2 g, yield 90%) as pale yellow prisms. Physical properties and spectral data are given in Table 1 .
2-(1,4-Dioxa-5-cyclopentyl)-4-guanidinophenol (5)
A solution of 4 (2.0 g, 4.1 mmol) in EtOH-Et 2 O (1 : 1) (250 ml) containing 10% Pd-C (100 mg) was vigorously stirred for 1 h under an atmosphere of hydrogen at room temperature. The catalyst was filtered off, and the filtrate was evaporated to dryness in vacuo. The solid residue was recrystallized from MeOH-Et 2 O to give 5 (0.8 g, yield 87%) as a pale brown crystalline powder.
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3-Formyl-4-hydroxyphenylguanidine Hydrochloride (6)
To a solution of 5 (1.12 g, 5.0 mmol) in EtOH (5 ml) was added 2 M HCl (5 ml), and the precipitate was collected. Recrystallization from EtOH-Et 2 O give a pale yellow crystalline powder (0.77 g, yield 71%). Physical properties and spectral data are given in Table 1 .
m-Guanidinosalicylidene-L-alaninato(aqua)copper(II) Hydrochloride (7b) Synthesis was carried out following the procedure reported for mamidinosalicylidene-L-alaninato(aqua)copper(II). 23) To a solution of 6 (0.22 g, 1.0 mmol) and L-alanine (0.09 g, 1.0 mmol) in water (2 ml) was added a solution of copper(II) acetate monohydrate (0.2 g, 1.0 mmol) in water (2 ml) and the mixture was stirred for 3 h at 50°C. The reaction mixture was concentrated and subjected to Sephadex LH-20 column chromatography using MeOH. The eluate was evaporated to dryness in vacuo, and the solid residue was recrystallized from H 2 O-EtOH to give 7b (0.30 g, yield 84%) as a green crystalline powder. Physical properties and spectral data are given in Table 2 .
m-Guanidinosalicylidene-L-alaninato(aqua)zinc(II) Hemihydrate Hydrochloride (8b) Synthesis was carried out by the same procedure reported for (N-salicylidene amino acidato)zinc(II) complexes. 36, 38) Equimolar amounts of 6, L-alanine, and zinc(II) acetate dihydrate (1.0 mmol) were dissolved in H 2 O-MeOH (15 ml), and the mixture was stirred for 8 h at room temperature. The reacted precipitate was collected by filtration. Complex was purified by recrystallization from H 2 O-EtOH and dried under a vacuum. A white powder was obtained (0.2 g, yield 53%). Physical properties and spectral data are given in Table 2 .
Potassium Bis(m-guanidinosalicylidene-L-alaninato)iron(III) Trihydrate (9b) Synthesis was carried out following the procedure reported for potassium bis(m-amidinosalicylidene-L-alaninato)iron(III) (12b). 24) A mixture of 6 (0.43 g, 2.0 mmol), L-alanine (0.18 g, 2.0 mmol), and potassium hydroxide (0.23 g, 4.1 mmol) in H 2 O-EtOH (15 ml) was stirred for several minutes at room temperature. To the reaction mixture, an ethanolic solution of iron(II) acetate enneahydrate (0.17 g, 1.0 mmol) was added over about 15 min. The solution was stirred for 8 h at room temperature and evaporated to dryness. The residue was subjected to a column chromatography on Sephadex LH-20 (MeOH). The eluate was concentrated until precipitation of the product occurred. The precipitate was collected by filtration, washed with EtOH and Et 2 O, and dried under a vacuum. A reddish brown powder was obtained (0.4 g, yield 31%). Physical properties and spectral data are given in Table 2 .
m-Amidinosalicylidene-L-alaninato(aqua)zinc(II) Hemihydrate Hydrochloride (10b) Equimolar amounts of 3-formyl-4-hydroxybenzamidine hydrochloride, L-alanine, and zinc(II) acetate dihydrate (1.0 mmol) were dissolved in H 2 O-MeOH (15 ml) and then mixture was stirred for 8 h at room temperature. The complex was purified by recrystallization from H 2 O-MeOH and dried under a vacuum. A white powder was obtained (0.2 g, yield 55%).
Determination of Inhibitory Activity (K i ) of Chelates Enzyme activity was determined in 50 mM Tris-HCl buffer containing 20 mM CaCl 2 (pH 8) using benzoyl-L-arginine p-nitroanilide (BAPA) as a substrate. Determination of K i values was carried out as follows: Concentrations of the inhibitor and trypsin used in the kinetic analysis were 10 Ϫ4 -10 Ϫ5 M and 10 Ϫ6 M, respectively. Hydrolytic rates in the presence of chelate were determined and the K i values were calculated according to the method of Dixon 42) using a linear regression program.
